A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. / Goode, Ellen L; Chenevix-Trench, Georgia; Song, Honglin; Ramus, Susan J; Notaridou, Maria; Lawrenson, Kate; Widschwendter, Martin; Vierkant, Robert A; Larson, Melissa C; Kjaer, Susanne K; Birrer, Michael J; Berchuck, Andrew; Schildkraut, Joellen; Tomlinson, Ian; Kiemeney, Lambertus A; Cook, Linda S; Gronwald, Jacek; Garcia-Closas, Montserrat; Gore, Martin E; Campbell, Ian; Whittemore, Alice S; Sutphen, Rebecca; Phelan, Catherine; Anton-Culver, Hoda; Pearce, Celeste Leigh; Lambrechts, Diether; Rossing, Mary Anne; Chang-Claude, Jenny; Moysich, Kirsten B; Goodman, Marc T; Dörk, Thilo; Nevanlinna, Heli; Ness, Roberta B; Rafnar, Thorunn; Hogdall, Claus; Hogdall, Estrid; Fridley, Brooke L; Cunningham, Julie M; Sieh, Weiva; McGuire, Valerie; Godwin, Andrew K; Cramer, Daniel W; Hernandez, Dena; Levine, Douglas; Lu, Karen; Iversen, Edwin S; Palmieri, Rachel T; Houlston, Richard; van Altena, Anne M; Aben, Katja K H; Wellcome Trust Case-Control Consortium.
I: Nature Genetics, Bind 42, Nr. 10, 01.10.2010, s. 874-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
AU - Goode, Ellen L
AU - Chenevix-Trench, Georgia
AU - Song, Honglin
AU - Ramus, Susan J
AU - Notaridou, Maria
AU - Lawrenson, Kate
AU - Widschwendter, Martin
AU - Vierkant, Robert A
AU - Larson, Melissa C
AU - Kjaer, Susanne K
AU - Birrer, Michael J
AU - Berchuck, Andrew
AU - Schildkraut, Joellen
AU - Tomlinson, Ian
AU - Kiemeney, Lambertus A
AU - Cook, Linda S
AU - Gronwald, Jacek
AU - Garcia-Closas, Montserrat
AU - Gore, Martin E
AU - Campbell, Ian
AU - Whittemore, Alice S
AU - Sutphen, Rebecca
AU - Phelan, Catherine
AU - Anton-Culver, Hoda
AU - Pearce, Celeste Leigh
AU - Lambrechts, Diether
AU - Rossing, Mary Anne
AU - Chang-Claude, Jenny
AU - Moysich, Kirsten B
AU - Goodman, Marc T
AU - Dörk, Thilo
AU - Nevanlinna, Heli
AU - Ness, Roberta B
AU - Rafnar, Thorunn
AU - Hogdall, Claus
AU - Hogdall, Estrid
AU - Fridley, Brooke L
AU - Cunningham, Julie M
AU - Sieh, Weiva
AU - McGuire, Valerie
AU - Godwin, Andrew K
AU - Cramer, Daniel W
AU - Hernandez, Dena
AU - Levine, Douglas
AU - Lu, Karen
AU - Iversen, Edwin S
AU - Palmieri, Rachel T
AU - Houlston, Richard
AU - van Altena, Anne M
AU - Aben, Katja K H
AU - Wellcome Trust Case-Control Consortium
PY - 2010/10/1
Y1 - 2010/10/1
N2 - Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2). Here, we report on nine additional candidate loci (defined as having P = 10¿4) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P = 5 × 10¿8 (8q24, P = 8.0 × 10¿¹5 and 2q31, P = 3.8 × 10¿¹4) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 × 10¿8 and 17q21, P = 1.4 × 10¿7). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
AB - Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2). Here, we report on nine additional candidate loci (defined as having P = 10¿4) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P = 5 × 10¿8 (8q24, P = 8.0 × 10¿¹5 and 2q31, P = 3.8 × 10¿¹4) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 × 10¿8 and 17q21, P = 1.4 × 10¿7). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
U2 - http://dx.doi.org/10.1038/ng.668
DO - http://dx.doi.org/10.1038/ng.668
M3 - Journal article
VL - 42
SP - 874
EP - 879
JO - Nature Genetics
JF - Nature Genetics
SN - 1061-4036
IS - 10
ER -
ID: 34157980